Transition to Levothyroxine 100 mcg Daily
Start levothyroxine 100 mcg daily and recheck thyroid function tests (TSH, free T4, free T3) in 4-6 weeks. Your patient is currently on Armour Thyroid 75 mg daily (15 mg × 5 tablets), which contains approximately 45 mcg of T4 and 11.25 mcg of T3 1. The low free T4 (0.64 ng/dL) and low free T3 (1.9 pg/mL) despite a normal TSH (1.07 µIU/mL) indicate inadequate peripheral thyroid hormone levels, likely due to the T4:T3 ratio in desiccated thyroid not providing sufficient T4 for endogenous T3 conversion.
Conversion Rationale
The standard conversion from desiccated thyroid to levothyroxine is approximately 60-65 mg of desiccated thyroid equals 100 mcg of levothyroxine 1. Your patient is on 75 mg of Armour Thyroid, which would convert to approximately 100-125 mcg of levothyroxine. I recommend starting at 100 mcg levothyroxine because:
- The patient's free T4 is significantly below normal (0.64 vs. reference range 0.82-1.77 ng/dL)
- Full replacement dosing for hypothyroidism is approximately 1.6 mcg/kg/day 1, 2
- The normal TSH suggests the patient has been adequately treated from a pituitary feedback perspective, but the low free T4 indicates insufficient T4 substrate for peripheral conversion
Administration Instructions
Instruct the patient to take levothyroxine consistently 30-60 minutes before breakfast with water on an empty stomach 1. This timing is critical for optimal absorption. Alternatively, it can be taken at bedtime, 4 hours after the last meal, though morning dosing typically ensures better compliance 1.
Monitoring Plan
- Recheck TSH and free T4 in 4-6 weeks after starting levothyroxine 1, 2
- The peak therapeutic effect may not be attained for 4-6 weeks 2
- Adjust dose in 12.5-25 mcg increments based on results 1
- Goal TSH should remain in the normal reference range (0.45-4.5 µIU/mL), ideally between 1-2.5 µIU/mL 1
- Goal free T4 should be in the mid-to-upper normal range 1
Critical Pitfalls to Avoid
Do not start with a lower dose simply because the TSH is normal. The low free T4 and free T3 indicate the patient needs adequate T4 replacement. The normal TSH is misleading here—it reflects the combined effect of both T4 and the supraphysiologic T3 content in desiccated thyroid, which provides direct T3 but insufficient T4 1.
Warn the patient about potential transient symptoms during the transition. The switch from desiccated thyroid (which provides immediate T3) to levothyroxine monotherapy (which relies on peripheral conversion to T3) may cause temporary symptoms in the first 2-4 weeks as the body adjusts. However, levothyroxine monotherapy is the preferred treatment and will provide more stable thyroid hormone levels throughout the day 1.
Ensure medication adherence and proper timing. The most common cause of persistently abnormal thyroid function tests in patients on levothyroxine is non-compliance or improper administration 1. Emphasize the importance of taking the medication consistently at the same time each day, away from food, calcium, iron supplements, or proton pump inhibitors that can interfere with absorption 1.
Age and Cardiac Considerations
If your patient is over 50-60 years old or has any cardiac risk factors (coronary artery disease, atrial fibrillation risk), consider starting at 50 mcg daily and titrating up by 12.5-25 mcg every 6-8 weeks 1, 2. However, given the normal TSH and the fact that the patient has been on thyroid hormone replacement, starting at 100 mcg is reasonable in a younger patient without cardiac disease.
Why Not Desiccated Thyroid?
Guidelines explicitly recommend against using desiccated thyroid hormone in preference to levothyroxine monotherapy 1. The T4:T3 ratio in desiccated thyroid (approximately 4:1 by weight) does not match human physiology, the hormone content can vary between preparations, and there is no systematic evidence supporting its use over levothyroxine 1.